198 related articles for article (PubMed ID: 11819931)
1. Serotonin-active drugs.
Rosenberg MD; Strassels SA
J Mass Dent Soc; 2000; 48(4):48-50. PubMed ID: 11819931
[No Abstract] [Full Text] [Related]
2. Serotonin receptors and therapeutics.
Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.
Kindt S; Tack J
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():32-9. PubMed ID: 17620086
[TBL] [Abstract][Full Text] [Related]
4. [Serotonin may be the key to the treatment of "irritable bowel disease"].
Sjövall H
Lakartidningen; 2001 May; 98(18):2166-71. PubMed ID: 11402594
[No Abstract] [Full Text] [Related]
5. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs.
DeBattista C; Sofuoglu M; Schatzberg AF
Biol Psychiatry; 1998 Sep; 44(5):341-7. PubMed ID: 9755356
[TBL] [Abstract][Full Text] [Related]
6. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Kind B; Fattinger K; Krähenbühl S; Meier-Abt PJ
Praxis (Bern 1994); 1996 Nov; 85(46):1490-2. PubMed ID: 8984572
[TBL] [Abstract][Full Text] [Related]
7. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].
Amelin AV; Skoromets AA; Ignatov IuD
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805
[No Abstract] [Full Text] [Related]
8. Acute and prophylactic management of migraine.
Dodick DW
Clin Cornerstone; 2001; 4(3):36-52. PubMed ID: 12739315
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and the GI tract.
Hasler WL
Curr Gastroenterol Rep; 2009 Oct; 11(5):383-91. PubMed ID: 19765366
[TBL] [Abstract][Full Text] [Related]
10. Preface. Physiological, pathophysiological and therapeutic aspects of 5-HT mechanisms.
Meneses A
Behav Brain Res; 2008 Dec; 195(1):1. PubMed ID: 18706936
[No Abstract] [Full Text] [Related]
11. Treatment of pediatric and adolescent migraine.
Hershey AD; Kabbouche MA; Powers SW
Pediatr Ann; 2010 Jul; 39(7):416-23. PubMed ID: 20666347
[No Abstract] [Full Text] [Related]
12. New findings in the treatment of panic disorder.
Westenberg HG; Den Boer JA
Pharmacopsychiatry; 1993 May; 26 Suppl 1():30-3. PubMed ID: 8378420
[TBL] [Abstract][Full Text] [Related]
13. [Prophylaxis of migraine].
Liaño H
Rev Neurol; 1995; 23 Suppl 2():S212-8. PubMed ID: 7497291
[No Abstract] [Full Text] [Related]
14. Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study.
MacGregor EA; Frith AA; Hackshaw A
J Clin Psychopharmacol; 2011 Jun; 31(3):392-3. PubMed ID: 21532361
[No Abstract] [Full Text] [Related]
15. Novel serotonergic mechanisms and clinical experience with nefazodone.
Fontaine R
Clin Neuropharmacol; 1993; 16 Suppl 3():S45-50. PubMed ID: 8131154
[TBL] [Abstract][Full Text] [Related]
16. Serotonin selective antidepressant drugs: past, present, future.
Asberg M; Mårtensson B
Clin Neuropharmacol; 1993; 16 Suppl 3():S32-44. PubMed ID: 8131153
[TBL] [Abstract][Full Text] [Related]
17. Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.
Johnson BA
CNS Drugs; 2004; 18(15):1105-18. PubMed ID: 15581381
[TBL] [Abstract][Full Text] [Related]
18. Practical considerations for the treatment of elderly patients with migraine.
Sarchielli P; Mancini ML; Calabresi P
Drugs Aging; 2006; 23(6):461-89. PubMed ID: 16872231
[TBL] [Abstract][Full Text] [Related]
19. Drugs to Treat Depression.
J Psychosoc Nurs Ment Health Serv; 2018 Jul; 56(7):7-8. PubMed ID: 29975393
[No Abstract] [Full Text] [Related]
20. Drugs to Treat Depression.
J Psychosoc Nurs Ment Health Serv; 2017 Jul; 55(7):5-6. PubMed ID: 28671235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
